Estimated date of event.Estimated date of implant.The device was not returned for analysis.A review of the lot history record and complaint history of the reported lot could not be conducted because the part and lot number were not provided.The reported patient effects of thrombosis and dissection are listed in the xience alpine everolimus eluting coronary stent systems instructions for use as known patient effects of coronary procedures.The investigation determined a conclusive cause for the reported patient-device incompatibility-wall apposition cannot be determined.Additionally, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.Article, titled "early vascular responses after everolimus-eluting stent implantation assessed by serial observations of intracoronary optical coherence tomography.".
|
It was reported through a research presentation identifying xience alpine stents that may be related to malaposition which led to dissection, thrombus, revascularization and rehospitalization.This article summarizes clinical outcomes of 45 patients that were treated with xience alpine stents.Specific patient information is documented as unknown.Details are listed in the article, titled "early vascular responses after everolimus-eluting stent implantation assessed by serial observations of intracoronary optical coherence tomography.".
|